CAR-T therapy revolutionized cancer care. Could it do the same for autoimmunity?

"Some people would think that this might be too good to be true, but it actually does look true," said immunologist Carola Vinuesa.

February 23, 2024 Check out STAT+

Sponsored By

Adobe Small study adds to growing hope CAR-T cell therapy could revolutionize autoimmune disease treatment A small study of lupus, scleroderma, and idiopathic inflammatory myositis found patients given CAR-T therapy had symptoms improve or go away. By Theresa Gaffney War zone or not, Ukraine seeks to reclaim its role as a hub for clinical trials Researchers and executives are increasingly urging companies to restart clinical trials, insisting that the war is an obstacle that can be surmounted. By Andrew Joseph STAT+ | Hospitals race to adopt generative AI, even as regulators struggle to keep up with the risks Large hospitals are experimenting with generative AI at a time when there are no standards for its use, or clear accounting of the risks. By Katie Palmer and Casey Ross

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser